GLP-1 receptor agonists lead a new wave of therapeutic options that may benefit patients with osteoarthritis, according to ...

Anti-obesity drugs such as semaglutide (Ozempic, Wegovy) are also promising for the treatment of alcohol use disorder and alcohol-associated liver disease, as growing evidence suggests they reduce the ...

"Type 2 diabetes in children and teens is increasing at an alarming rate, yet treatment options are limited, and this patient population remains underserved," said Kenneth Custer, Ph.D., executive ...

As GLP-1 drugs reshape eating habits, the food industry faces new challenges - and opportunities - in sugar reduction, taste, ...

GLP-1 is a natural human hormone that regulates blood glucose levels. Scientists have now created long-lasting GLP-1 drugs ...

Obesity treatment is hurtling into a new era: once-a-week GLP-1 injections are edging toward the dramatic results of ...

India has cleared Ozempic, the once-a-week semaglutide injection from Novo Nordisk, for adults with type 2 diabetes.

Ozempic may improve blood sugar a few weeks after starting, with full results appearing after about eight weeks. For weight ...

Much excitement has built in recent years on the new class of incretin drugs that include glucagon-like-peptide-1 inhibitor (single agonists such as semaglutide) and also dual glucose-dependent ...

Ozempic has taken TikTok by storm. It’s hailed as a miracle weight loss drug that helps you shed the pounds without even ...

Efficacy of tirzepatide does not differ significantly between men and women, despite sex-specific differences in ...

A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug addiction, according to a new paper published in the Journal of the Endocrine ...